Jim Cullen
Cullen Value Fund
Jim Cullen Johnson & Johnson stake
total: 74
Cullen Value Fund JNJ trades
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 2
- Reduced:
- 2
- Held since:
- 2019 Q3
- Held for:
- 27 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q1 report, Jim Cullen holds 3,988 Johnson & Johnson (JNJ) shares with a market value of roughly $974.83K accounting for 3.43% of the overall portfolio. To date, the estimated cost basis is nearly $133.4 for "buy" trades and estimated average "sell" price is $145.99. Cullen Value Fund first purchased JNJ in 2019 Q3, initially acquiring 5,915 shares. Since the initial investment in Johnson & Johnson (JNJ), Cullen Value Fund has made 4 more transactions.
When did Jim Cullen buy Johnson & Johnson (JNJ)?
Jim Cullen first invested in Johnson & Johnson (JNJ) in 2019 Q3 at the reported quarter-end price of $129.38 per share.
What's the cost basis of Cullen Value Fund's JNJ stake?
The estimated cost basis for Johnson & Johnson (JNJ) stake is around $133.40 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $133.40
- Weighted AVG sell price:
- $145.99
Jim Cullen's historical trades in Johnson & Johnson
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
2.72%
|
3,988
|
$162.06
|
$646,295
|
+22.37% (+729)
|
+0.5%
|
|
2024 Q2
|
2.12%
|
3,259
|
$146.16
|
$476,335
|
-25.51% (-1,116)
|
-0.7%
|
|
2023 Q3
|
3.27%
|
4,375
|
$155.75
|
$681,406
|
+3.06% (+130)
|
+0.1%
|
|
2019 Q4
|
2.07%
|
$145.87
|
-28.23% (-1,670)
|
|||
|
2019 Q3
|
1.97%
|
$129.38
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.